Form 4 holding
Chief Executive Officer, Director
Inmune Bio, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 750,000
- Estimated value
- Report date
- 01 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount